|
4 Companies |
|
2 Products |
|
2 Products |
|
2 Mechanisms of Action |
|
0 Trials |
|
52 News |
|
| 12» |
- | Trial completion, Phase classification, Enrollment change, Trial primary completion date: Surgical Success After Laparoscopic vs Abdominal Hysterectomy (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=100, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Completed | Phase classification: P4 --> PN/A | N=75 --> 100 | Trial primary completion date: Jun 2016 --> Dec 2016
- |||| Invanz (ertapenem) / Merck (MSD)
Trial completion: An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038) (clinicaltrials.gov) - Feb 16, 2017
P2, N=100, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed | Phase classification: P4 --> PN/A | N=75 --> 100 | Trial primary completion date: Jun 2016 --> Dec 2016 No longer recruiting --> Completed
- Trial completion, Trial primary completion date: The Role of Novel Organisms in Acute Endometritis (clinicaltrials.gov) - Aug 17, 2016
P=N/A, N=480, Completed, Sponsor: Sharon Hillier
No longer recruiting --> Completed Enrolling by invitation --> Completed | Trial primary completion date: Aug 2014 --> Aug 2015
- |||| azithromycin / Generic mfg.
Trial completion, Trial primary completion date: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Aug 2, 2016
P4, N=400, Completed, Sponsor: Pfizer
Enrolling by invitation --> Completed | Trial primary completion date: Aug 2014 --> Aug 2015 Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016
- Trial completion, Trial primary completion date: Peri-Op: Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity (clinicaltrials.gov) - Jun 22, 2016
P=N/A, N=606, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016 Recruiting --> Completed | Trial primary completion date: Dec 2009 --> Mar 2010
- Trial primary completion date: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Apr 25, 2016
P2, N=233, Completed, Sponsor: Harold Wiesenfeld
Recruiting --> Completed | Trial primary completion date: Dec 2009 --> Mar 2010 Trial primary completion date: Mar 2015 --> Aug 2015
- Trial completion, Enrollment change: Immunopathogenesis of Chlamydia (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=29, Completed, Sponsor: Arkansas Children's Hospital Research Institute
Trial primary completion date: Mar 2015 --> Aug 2015 Enrolling by invitation --> Completed | N=300 --> 29
- azithromycin / Generic mfg.
Trial primary completion date: C/SOAP: Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=2013, Completed, Sponsor: Alan Tita
Enrolling by invitation --> Completed | N=300 --> 29 Trial primary completion date: Feb 2015 --> Dec 2015
- || azithromycin / Generic mfg.
Trial primary completion date: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Feb 21, 2016
P4, N=400, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: Feb 2015 --> Dec 2015 Trial primary completion date: May 2016 --> Nov 2015
- ||| azithromycin / Generic mfg.
Enrollment closed, Phase classification, Trial primary completion date: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Feb 9, 2016
P4, N=400, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: May 2016 --> Nov 2015 Completed --> Active, not recruiting | Phase classification: PN/A --> P4 | Trial primary completion date: Nov 2015 --> May 2016
- ||| azithromycin / Generic mfg.
Trial completion: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=403, Completed, Sponsor: Pfizer
Completed --> Active, not recruiting | Phase classification: PN/A --> P4 | Trial primary completion date: Nov 2015 --> May 2016 Active, not recruiting --> Completed
- Trial completion: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Dec 5, 2015
P2, N=233, Completed, Sponsor: Harold Wiesenfeld
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=100, Completed, Sponsor: OVO R & D
Active, not recruiting --> Completed Recruiting --> Completed
- || azithromycin / Generic mfg.
Trial primary completion date: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Jun 25, 2015
P4, N=400, Active, not recruiting, Sponsor: Pfizer
Recruiting --> Completed Trial primary completion date: Jun 2016 --> Aug 2015
- Enrollment closed: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Jun 3, 2015
P2, N=250, Active, not recruiting, Sponsor: Harold Wiesenfeld
Trial primary completion date: Jun 2016 --> Aug 2015 Recruiting --> Active, not recruiting
- azithromycin / Generic mfg.
Trial completion: C/SOAP: Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection (clinicaltrials.gov) - May 26, 2015
P=N/A, N=2013, Completed, Sponsor: Alan Tita
Recruiting --> Active, not recruiting Recruiting --> Completed
- cefazolin / Generic mfg., azithromycin / Generic mfg.
Trial withdrawal: Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis (clinicaltrials.gov) - May 5, 2015
P4, N=0, Withdrawn, Sponsor: University of Missouri, Kansas City
Recruiting --> Completed Terminated --> Withdrawn
- ||| azithromycin / Generic mfg.
Enrollment closed: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Feb 9, 2015
P4, N=400, Active, not recruiting, Sponsor: Pfizer
Terminated --> Withdrawn Enrolling by invitation --> Active, not recruiting
- Trial primary completion date: Surgical Success After Laparoscopic vs Abdominal Hysterectomy (clinicaltrials.gov) - Dec 19, 2014
P4, N=75, Recruiting, Sponsor: University of Texas Southwestern Medical Center
Enrolling by invitation --> Active, not recruiting Trial primary completion date: Jun 2015 --> Jun 2016
- clindamycin phosphate / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: TUPAC: Treatment Utility of Postpartum Antibiotics in Chorioamnionitis (clinicaltrials.gov) - Dec 10, 2014
P4, N=80, Terminated, Sponsor: Washington University School of Medicine
Trial primary completion date: Jun 2015 --> Jun 2016 N=238 --> 80 | Recruiting --> Terminated | Trial primary completion date: Jul 2013 --> Jul 2014; Futility in patient enrollment
- | azithromycin / Generic mfg.
Phase classification: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Dec 9, 2014
P4, N=400, Enrolling by invitation, Sponsor: Pfizer
N=238 --> 80 | Recruiting --> Terminated | Trial primary completion date: Jul 2013 --> Jul 2014; Futility in patient enrollment Phase classification: P=N/A --> P4
- Trial primary completion date: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Dec 5, 2014
P2, N=250, Recruiting, Sponsor: Harold Wiesenfeld
Phase classification: P=N/A --> P4 Trial primary completion date: Aug 2014 --> Mar 2015
- Trial completion: POPI: Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease (clinicaltrials.gov) - Nov 24, 2014
P=N/A, N=2531, Completed, Sponsor: St George's, University of London
Trial primary completion date: Aug 2014 --> Mar 2015 Active, not recruiting --> Completed
- Trial completion: Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease (clinicaltrials.gov) - Oct 28, 2014
P=N/A, N=95, Completed, Sponsor: Children's Hospital of Philadelphia
Active, not recruiting --> Completed Recruiting --> Completed
- cefazolin / Generic mfg., azithromycin / Generic mfg.
Enrollment change, Trial termination: Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis (clinicaltrials.gov) - Sep 28, 2014
P4, N=9, Terminated, Sponsor: University of Missouri, Kansas City
Recruiting --> Completed N=506 --> 9 | Recruiting --> Terminated; Poor enrollment
- | azithromycin / Generic mfg.
Phase classification: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Sep 11, 2014
P=N/A, N=400, Enrolling by invitation, Sponsor: Pfizer
N=506 --> 9 | Recruiting --> Terminated; Poor enrollment Phase classification: P4 --> P=N/A
- Trial primary completion date: Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=94, Recruiting, Sponsor: Children's Hospital of Philadelphia
Phase classification: P4 --> P=N/A Trial primary completion date: Jul 2014 --> Nov 2014
- || Enrollment change: Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=100, Recruiting, Sponsor: OVO R & D
Trial primary completion date: Jul 2014 --> Nov 2014 N=60 --> 100
- ||| Enrollment open, Enrollment change: Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=100, Recruiting, Sponsor: OVO R & D
N=60 --> 100 Completed --> Recruiting | N=60 --> 100
- ||| Trial completion: Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization (clinicaltrials.gov) - Mar 11, 2014
P=N/A, N=60, Completed, Sponsor: OVO R & D
Completed --> Recruiting | N=60 --> 100 Recruiting --> Completed
- Invanz (ertapenem) / Merck (MSD)
Trial termination: Pharmacokinetics and Safety of Ertapenem in the Postpartum Period (clinicaltrials.gov) - Jan 21, 2014
P1, N=3, Terminated, Sponsor: Daniel Benjamin
Recruiting --> Completed Recruiting --> Terminated; study terminated due to low subject accrual
- Invanz (ertapenem) / Merck (MSD)
Enrollment change: Pharmacokinetics and Safety of Ertapenem in the Postpartum Period (clinicaltrials.gov) - Jan 21, 2014
P1, N=3, Terminated, Sponsor: Daniel Benjamin
Recruiting --> Terminated; study terminated due to low subject accrual N=24 --> 3
- azithromycin / Generic mfg.
Trial completion: PKAZ: The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery (clinicaltrials.gov) - Nov 17, 2013
P=N/A, N=30, Completed, Sponsor: University of Alabama at Birmingham
N=24 --> 3 Recruiting --> Completed
- Trial completion: Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials (clinicaltrials.gov) - Aug 26, 2013
P4, N=1303, Completed, Sponsor: Istanbul Bakirkoy Maternity and Children Diseases Hospital
Recruiting --> Completed Recruiting --> Completed
- cefazolin / Generic mfg., azithromycin / Generic mfg.
Enrollment open: Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis (clinicaltrials.gov) - Apr 7, 2013
P4, N=506, Recruiting, Sponsor: University of Missouri, Kansas City
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials (clinicaltrials.gov) - Mar 11, 2013
P4, N=1303, Completed, Sponsor: Istanbul Bakirkoy Maternity and Children Diseases Hospital
Not yet recruiting --> Recruiting N=610 --> 1303
- Enrollment open: Surgical Success After Laparoscopic vs Abdominal Hysterectomy (clinicaltrials.gov) - Feb 26, 2013
P4, N=75, Recruiting, Sponsor: University of Texas Southwestern Medical Center
N=610 --> 1303 Not yet recruiting --> Recruiting
- | New P4 trial: Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials (clinicaltrials.gov) - Feb 24, 2013
P4, N=1303, Completed, Sponsor: Istanbul Bakirkoy Maternity and Children Diseases Hospital
- | New P4 trial: Surgical Success After Laparoscopic vs Abdominal Hysterectomy (clinicaltrials.gov) - Feb 13, 2013
P4, N=75, Recruiting, Sponsor: University of Texas Southwestern Medical Center
- | cefazolin / Generic mfg., azithromycin / Generic mfg.
New P4 trial: Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis (clinicaltrials.gov) - Nov 4, 2012
P4, N=506, Recruiting, Sponsor: University of Missouri, Kansas City
- | Enrollment change, Combination therapy: A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection (clinicaltrials.gov) - Oct 28, 2012
P3, N=38, Completed, Sponsor: Pfizer
Not yet recruiting --> Recruiting N=30 --> 38
- |||| azithromycin / Generic mfg.
Enrollment open: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Oct 28, 2012
P4, N=400, Enrolling by invitation, Sponsor: Pfizer
N=30 --> 38 Not yet recruiting --> Enrolling by invitation
- || Trial completion, Combination therapy: A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection (clinicaltrials.gov) - Oct 28, 2012
P3, N=38, Completed, Sponsor: Pfizer
Not yet recruiting --> Enrolling by invitation Recruiting --> Completed
- Enrollment change: Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine (clinicaltrials.gov) - Sep 16, 2012
P=N/A, N=44, Completed, Sponsor: University of South Florida
Recruiting --> Completed N=320 --> 44
- Trial completion: Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine (clinicaltrials.gov) - Sep 16, 2012
P=N/A, N=44, Completed, Sponsor: University of South Florida
N=320 --> 44 Recruiting --> Completed
- ||||| azithromycin / Generic mfg.
New P4 trial: RESCUE: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Aug 21, 2012
P4, N=400, Enrolling by invitation, Sponsor: Pfizer
- || ampicillin / Generic mfg., gentamicin sulfate / Generic mfg.
New P2/3 trial: Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term (clinicaltrials.gov) - Jul 2, 2012
P2/3, N=161, Completed, Sponsor: Hospital de Santa Maria, Portugal
- Invanz (ertapenem) / Merck (MSD)
New P1 trial: Pharmacokinetics and Safety of Ertapenem in the Postpartum Period (clinicaltrials.gov) - Apr 26, 2012
P1, N=3, Terminated, Sponsor: Daniel Benjamin
- | clindamycin phosphate / Generic mfg.
New P4 trial: TUPAC: Treatment Utility of Postpartum Antibiotics in Chorioamnionitis (clinicaltrials.gov) - Apr 22, 2012
P4, N=238, Recruiting, Sponsor: Washington University School of Medicine
- ||| New P3 trial, Combination therapy: A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection (clinicaltrials.gov) - Nov 15, 2011
P3, N=38, Completed, Sponsor: Pfizer